We spoke with Caroline Crooms, MD, a neurologist at Mount Sinai Health System, to discuss how patients and caregivers can navigate the complex choices that come with a diagnosis so they can make informed decisions about their care: https://bit.ly/4cTMjPq
#MyTumorID
Learn more about why biomarker testing matters and how it can inform decisions about your care through our #MyTumorID resources: braintumor.org/brain-tumors...
🧠 “With #MyTumorID, I decide.”
Consider these key questions & discuss with your care team to ensure your treatment aligns with your goals & the latest advancements.
Find the full list here: braintumor.org/brain-tumors/diagnosis-t...
“Biomarker testing helped me understand my #braintumor, eased fears for my daughters, and gave me confidence in decisions about my care. We need more awareness of #biomarkertesting.” — Amanda D.
Read her story: https://bit.ly/4r8U4Fd
#MyTumorID #meningioma
🔬 Learn more about biomarker testing and how it can help you make informed decisions about your care at MyTumorID.org
#MyTumorID
Ben S-L pushed for #BiomarkerTesting after an inoperable brainstem glioma diagnosis and it led him to ONC201.
7 years later, his tumor has shrunk.
Read Ben’s story: braintumor.org/news/how-biomarker-testi...
#MyTumorID
Their story sheds light on life with high-grade, IDH-mutant astrocytoma and why biomarker testing and clinical trials matter for people living with brain tumors.
Learn how biomarker testing can help identify treatment options, including clinical trials, at MyTumorID.org.
#MyTumorID
Our impact is so much greater when we partner with others. This year we:
🤝Co-promoted #MyTumorID with affiliate organizations
🤝Connected private industry with academic research through #BTIF
🤝Convened thought leaders to plan the future of neuro-oncology therapy development
🙏 This week of Thanksgiving, our NBTS team extends a note of heartfelt gratitude to our five amazing #MyTumorID Affiliate Partners.
We are so much stronger together, and our collective impact for the brain tumor community is greater, thanks to these notable organizations.
Heading to #SNO2025?
Visit our NBTS booth to learn more about #MyTumorID, our public health campaign advancing awareness of and access to biomarker testing and clinical trials for patients with a #braintumor.
#BiomarkerTesting helps doctors recommend the most effective treatments based on a tumor’s unique profile, empowering patients to make more informed decisions.
Today, on the first-ever Cancer Biomarker Awareness Day, reshare this #MyTumorID video to help improve access and outcomes.
Please join us in welcoming the Pediatric Brain Tumor Foundation (PBTF) as the newest member of the #MyTumorID Affiliate Program.
In this role, the PBTF continues their notable work in supporting families through a pediatric brain tumor diagnosis.
⏳ Last chance!
Join us tomorrow, Oct 24, for the latest #MyTumorID webinar, "Let’s Talk About Clinical Trials: With MyTumorID, I Decide."
Don’t miss this powerful conversation: braintumor.org/brain-tumors/diagnosis-treatment/mytumorid/webinars/lets-talk-about-clinical-trials
#ClinicalTrials
Please join us in welcoming the Glioblastoma Research Organization (GBMRO) as the newest member of the #MyTumorID Affiliate Program.
Together, we are boosting awareness about the importance of biomarker testing and clinical trials for patients with #braintumors
Clinical trial eligibility often depends on factors like #braintumor type, overall health, and results from biomarker testing.
Join our #MyTumorID webinar on Oct. 24 to learn more about how clinical trials work: braintumor.org/brain-tumors...
Discover why identifying your brain tumor at the molecular level matters at mytumorid.org
#MyTumorID
Accurately identifying Darlene’s brain tumor changed everything.
Instead of a “watch and wait” approach, her care team started treatment immediately, giving Darlene and the Peterson family more time together.
#MyTumorID
For the Peterson family, biomarker testing gave them clarity — what was first thought to be a low-grade glioma turned out to be grade 4 glioblastoma.
#MyTumorID
Biomarker testing showed that Stephen's #braintumor was more aggressive than it looked under the microscope, changing his treatment plan.
Learn about the importance of biomarker testing at our free #MyTumorID webinar on Fri 9/26.
Register now: braintumor.org/brain-tumors...
Biomarker testing doesn’t just help doctors accurately diagnose a child’s #braintumor, it can also open the door to potential targeted therapies & determine clinical trial eligibility: braintumor.org/news/lets-talk-about-pediatric-brain-tumor-biomarkers
#MyTumorID #ChildhoodCancerAwarenessMonth
Thanks to biomarker testing, Eloise’s family learned her #braintumor was benign — not aggressive #DMG.
That knowledge gave her family hope and allowed them to make informed decisions about her care.
Read their story: braintumor.org/news/eloises-story-livin...
#MyTumorID
When Ben received #biomarkertesting results after his #braintumor diagnosis, his world shifted –– and a new treatment option became available to him.
Register today to join our free #MyTumorID biomarker testing webinar on Fri 9/26: braintumor.org/brain-tumors...
At just 26, Julia was told she might have an aggressive #braincancer with a 10-year prognosis, but biomarker testing revealed a low-grade tumor.
Learn about the importance of biomarker testing at our free #MyTumorID webinar on Fri 9/26.
Register today: braintumor.org/brain-tumors...
💻 Join us for two free #MyTumorID webinars designed to help patients and caregivers learn about biomarker testing (Sept. 26) and clinical trials (Oct. 24) to make the most informed decisions about your treatment.
Sign up today: braintumor.org/brain-tumors/diagnosis-treatment/mytumorid/webinars/
Then, check out our 5 tips for how to talk to your doctor about biomarker testing: braintumor.org/news/5-tips-...
#MyTumorID
🧬 What is biomarker testing, and why is it so important for patients with #braintumors?
In this #MyTumorID video, learn how biomarker testing helps identify the molecular and genetic makeup of your tumor, guiding more precise diagnoses and treatment options, including potential clinical trials.
To make informed decisions about their treatment, patients with #braintumors and their care partners can actively explore clinical trial options on their own and discuss them with their care team instead of waiting for a provider to mention an opportunity.
#MyTumorID
Matt C. was relaxing with his sons when he had his first seizure.
A CT scan revealed a brain tumor, thought to be #oligodendroglioma. Biomarker testing later determined it was a grade 3 #astrocytoma.
Read his story: braintumor.org/news/one-foo...
#MyTumorID
Learn more about why #clinicaltrials matter at braintumor.org/brain-tumors...
#MyTumorID
🔬 Ever wonder what happens to your #braintumor after biopsy or surgery?
Pathologists like Keith Ligon, MD, PhD, analyze it under a microscope and then perform additional biomarker testing to determine a complete diagnosis.
Learn more: braintumor.org/news/qa-with...
#MyTumorID
